1. P404 Persistence of subcutaneous infliximab after switching from intravenous in a French national cohort of IBD patients in remission. (30th January 2023) Authors: Mathieu, N; Riviere, P; Heluwaert, F; Hébuterne, X; Chupin, A; Bouguen, G; Vuitton, L; Allez, M; Montuclard, C; Nachury, M; Nancey, S; Amélie, B; Gilletta, C; Abitbol, V; Altwegg, R; de Maissin, A; Plastaras, L; Ah Soune, P; Boureille, A; Bouhnik, Y Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i533 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗